Guidance

Genomics and personalised medicines: partner with the UK to develop new treatments

Overview of UK research infrastructure for genomics technologies, and advantages of investment in the UK's life science sector to support new products.

From:
Life Sciences Organisation and Department for International Trade
Published
2 July 2019

Documents

Genomics and personalised medicine: partner with the UK to develop new treatments, diagnostics, and care solutions

HTML

Details

A summary of the UK’s strengths as a partner for genomics technologies and development of personalised medicines, including information on:

  • research and development expertise
  • clinical research infrastructure
  • routes to product development
  • regulatory approval
Published 2 July 2019

Related content